Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
Login to comment.